04/09/2024
3:25 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:17 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
10:24 AM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:18 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
11:53 AM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
2:22 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:36 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/08/2024
6:45 AM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
12:37 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:10 PM | Apellis Pharmaceuticals (Filer)
| Form 10-K/A | |
02/27/2024
6:35 AM | Apellis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:30 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:01 AM | Apellis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
4:18 PM | Apellis Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:23 AM | Apellis Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
2:19 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:22 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:27 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:28 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:43 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:46 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
3:34 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:36 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:38 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:26 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:28 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:31 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
9:50 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
9:04 AM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:15 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:15 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:17 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:19 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
6:28 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:13 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:15 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:17 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:00 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
New crypto project uncovers 2,050% in 65 days (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
01/23/2024
5:01 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:03 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:05 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:07 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:11 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
11:36 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
9:21 AM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:33 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:34 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:14 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:18 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:18 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:19 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:21 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:21 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:21 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:23 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
7:00 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
3:54 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:55 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:47 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:37 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:38 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:40 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:41 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:43 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:45 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:32 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:33 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:36 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
11:24 AM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
9:46 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
9:18 AM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:48 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:49 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:50 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:51 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:53 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:41 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:44 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:44 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:47 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:07 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:14 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
Baumal Caroline (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:09 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:10 PM | Apellis Pharmaceuticals (Issuer)
Chan Gerald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:12 PM | Apellis Pharmaceuticals (Issuer)
O'Brien Stephanie Monaghan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:13 PM | Apellis Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:13 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
New crypto project uncovers 2,050% in 65 days (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
12/27/2023
10:04 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
2:24 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
3:18 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
11:43 AM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
6:04 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
6:40 PM | Apellis Pharmaceuticals (Issuer)
SCHEIBLER LUKAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
6:29 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:21 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
6:24 PM | Apellis Pharmaceuticals (Subject)
Dunlop A. Sinclair (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
